Introduction
Textile technologies developed for making clothing and decorative fabrics can produce fi nely tuned 2D and 3D constructs with exquisite control over their size, shape, and porosity from
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natural or synthetic fi bers. [1] [2] [3] These characteristics elevate the textile technologies including weaving, knitting, and braiding to an attractive platform for engineering artifi cial organs for both transplantation and research purposes. [4] [5] [6] Textile technologies have been exploited to mimic important mechanical characteristics of natural tissues, such as the anisotropy of cardiac muscle, tendon, and vascular walls, [ 5, 7, 8 ] which are known to control cellular behavior and activity. [ 9 ] In an interesting study, Moutos et al. used a customized loom to weave a 3D scaffold from poly(glycolic acid) (PGA) microfi bers. [ 4 ] These scaffolds served to reinforce an agarose hydrogel construct loaded with porcine articular chondrocytes. The mechanical properties and microstructure of the fabricated scaffolds were adjusted to match the anisotropy and tension-compression nonlinearity of native articular cartilage. [ 4 ] In another study, Dai et al. created a 3D hybrid scaffold by incorporating a type I collagen within a poly(lactic-co-glycolic acid) (PLGA) knitted mesh for cartilage regeneration. [ 5 ] The knitted structure served as a reinforcing structure while collagen enhanced cell adhesion and tissue formation. Freeman et al. created poly(Llactic acid) (PLLA) braid-twist scaffolds and showed that by adjusting the braiding and twisting angles, the mechanical properties of the created scaffolds could be tailored to simulate the biomechanical profi le and mechanical properties of anterior cruciate ligament. [ 10 ] However, all these scaffolds were formed from lifeless fi bers and cells had to be added after the fact. Thus, the ability to deliver cells inside of the scaffold and to control the distribution and organization of different cell types were lacking.
The incorporation of cells into the fi bers prior to processing into a larger construct offers a tantalizing prospect of cell delivery both at the surface and deep within the construct with exquisite positional control while the construct is being shaped. Common methods to create cell-laden fi bers include electrospining, [ 11 ] wetspinning, [ 12 ] microfl uidic spinning [ 6, 13, 14 ] , and interfacial complexation. [ 15 ] Among these methods, microfl uidic and wetspinning offer excellent control over the size, morphology, and biochemical composition of the fi bers. [ 6, 13, 14 ] In a recent study, Oneo et al. developed a double-coaxial laminar fl ow microfl uidic device to create meter-long functional microfi bres with a mixture of extracellular matrix proteins and cells as the core and Ca-alginate as the shell. [ 6 ] The authors stated that handling of the woven structure was challenging and required a support made from another hydrogel, indicating that the mechanical strength of the fi bers was not suffi cient. By using great care and efforts, microfi bers were assembled into cellular constructs that mimicked intrinsic morphologies and functions of living tissues by weaving and winding, highlighting the potential of living fi bers in tissue engineering. For these techniques to gain traction, and be used widely and routinely, much more complex structures should be developed. Thus, living fi bers that can be handled with ease and withstand the forces applied during weaving, winding, braiding, knitting, and embroidering are needed. Mechanically strong fi bers will also be useful for making tissues that require high mechanical strength, such as connective tissues, vascular grafts, and bone.
Here, we introduce core-shell composite living fi bers (CLFs) that comprise a mechanically rigid core and a soft shell made of a hydrogel seeded with living cells. CLFs easily withstand the mechanical constraints imposed by commonly used textile manufacturing processes including knitting, braiding, weaving, and embroidering. Indeed, CLFs possess the mechanical strength of the core thread made of single and multi-fi laments, biodegradable, and non-biodegradable suturing threads, while providing a suitable environment for the proliferation of cells encapsulated within the hydrogel layer that were coated around the core thread. We assembled CLFs into 2D and 3D cell-laden constructs using the gamut of textile techniques, demonstrating the versatility of CLFs while confi rming the integrity of the hydrogels and the viability of various cells. Using our approach a core material and a hydrogel comprising cells or drug microparticles can be freely combined, offering great freedom for designing scaffolds with tunable mechanical properties and programmable cell distribution.
Results and Discussion

CLF Fabrication
A schematic of the CLF manufacturing process and the actual fabricated device are shown in Figure 1 a,b. Threads were steadily drawn through a sequence of baths containing calcium chloride (CaCl 2 ) and Na-alginate prepolymers mixed with cells (or beads) using a motorized spool. The coating layer thickness was adjusted by changing the drawing speed ( Figure 1 c-e) . The thickness of the hydrogel layer could be increased by increasing the drawing speed, which dragged along more solution, or by using a higher concentration (and viscosity) of Na-alginate (Figure 1 f) . The fi rst CaCl 2 bath wets the surface and fi lls the pores (for braided or twisted threads) by capillarity and promotes the gelation of Ca-alginate on the surface and the inside of the thread. The second CaCl 2 bath completed the crosslinking of the Na-alginate by exchanging the Na + with Ca + to form a hydrogel network. A dripper loaded with tris-buffered saline (TBS) continuously rinsed the CLF at the collecting spool to rinse off excessive CaCl 2 and ensure a humid environment (Figure 1 a) . We used alginate as an example to demonstrate our technology for engineering composite living fi bers. Alginate is easy to use, gels quickly, and is approved by the FDA for certain applications. The concept of composite living fi bers, however, is not limited to alginate and other types of hydrogels including photocrosslinkable materials such as methacrylated gelatin (GelMA, see further below) and thermally crosslinkable hydrogels such as collagen and gelatin can be used in this process. Moreover, alginate can be functionalized with RGD-containing cell adhesion ligands or can be blended with other biopolymers such as gelatin or collagen for applications, where cell spreading within 3D hydrogels is essential. [ 16, 17 ] CLFs were made from multifi lament twisted cotton, biodegradable suturing threads, including monofi lament (polydioxanone), braided multifi lament (polyglycolic acid), and gut thread ( Figure 2 a-d). Cells and beads were suspended in Na-alginate solutions before coating according to the protocol described in the experimental section. We noticed that the morphology, structure, and surface properties of the core thread governed the formation and uniformity of the hydrogel layer. Monofi lament and braided suturing threads yielded homogeneous coatings compared to cotton threads, which comprise many loose fi laments. We plasma treated non-absorbable polypropylene suturing threads to render their surface hydrophilic and to coat a uniform layer of hydrogel on their surface.
Using our fabrication method, it was easy to make multilayer fi bers simply by adding more reservoirs containing Naalginate and CaCl 2 to the process shown in Figure 1 . We used this technique in one case to coat a braided suturing thread with a hydrogel layer comprising submicrometer beads (green) as a representative of microcapsules containing biomolecules followed by a layer containing human embryonic kidney (HEK293) (red), Figure 1 e. In another example, a core thread was coated with human umbilical vein endothelial cells (HUVECs) covered by osteoblast precursor cells (MC3T3) (Figure 1 f). These two cells are known to interact and promote the formation of vascularized bone tissues. [ 7 ] Using this method, it is possible to apply different cells and materials as separate layers onto a single fi ber, which will be of interest for tissue engineering applications that require co-cultures of different cell types or drug releasing microcapsules.
Viability Assessment
To assess the biocompatibility of our approach, we performed a live/dead cell assay and determined the cell viability using the This data is consistent with other studies [ 16 ] and our results obtained from cells cultured in wetspun fi bers as control group ( Figure S2a , Supporting Information). To investigate cell proliferation in CLFs, we counted the total number of cells over the seven days of incubation. The linear density of cells (number of cells per cm of thread) increased from 6800 to 12 400 cells cm −1 between day 1 and day 7 of culture, demonstrating that the cells were proliferating (Figure 3 e) . Whereas initially cells proliferated rapidly, the lack of adhesion and the absence of migration limited the cell proliferation.
CLFs Assembly using Textile Techniques
To test the compatibility of the CLFs with common textile techniques, complex 2D and 3D structures were made by weaving, braiding, knitting, winding, and embroidering under sterile condition. In weaving, warp threads were pre-stretched across the loom and the weft thread was woven across in the perpendicular direction. The diameter, strength, spacing, and the tension of both warp and weft can be used to tune the strength, porosity, morphology, and geometry of the fabric ( Figure 4 a-i).
Woven structures are usually two-dimensional, lightweight, and fl exible and have been used to make scaffolds for cartilage tissue engineering. [ 4, 18 ] The microstructure of the woven construct can be tailored to meet the mechanical properties of the native tissue and enhance the transport of nutrients and oxygen to cells. [ 4 ] We modifi ed an off-the-shelf manual weaving loom to weave CLFs ( Figure S1a , Supporting Information). Two meters of HEK293 loaded CLFs (wefts) were passed through monofi lament cell-free suturing threads (warps) to form a 1.5 cm × 2 cm woven structure (Figure 4 a,ii-iv). The fabricated woven structure was mechanically stable and could easily be manipulated during weaving, and afterwards. Moreover, the hydrogel layer withstood all imposed mechanical forces during the weaving process and remained intact. These initial promising results suggest that it may be possible to scale up the process as well as to use automated weaving looms for a variety of applications, ( Figure S1b , Supporting Information). An important point to consider is that the weaving process was conducted in a wet condition, which is not common for textile machinery. Knitting creates structures by intertwining yarns or threads in a series of connected loops in 2D or 3D (Figure 4 b,i) that enables creating complex patterns. Knitted structures provide mechanical strength both in-plane and across-plane, unlike woven structures that are 2D. [ 1 ] Knitted structures have found a wide range of applications in regenerative medicine as scaffolds for engineering cartilage, [ 19 ] skin, [ 20 ] bone, [ 21 ] ligament, [ 22 ] and vascular grafts. [ 23 ] We utilized our cell-and bead-laden CLFs to fabricate a multi colored 3D knitted fabric and a donut-like construct (Figure 4 b,ii,vi) . The latter construct had inner and outer diameters of 5 mm and 25 mm, respectively and was made with 1.5 m of CLF (Figure 4 b,vi) .
Braiding is the intertwining of three or more fi ber strands (Figure 4 c) and allows for making complex cylindrical structures or patterns. Braided scaffolds replicate both the geometrical dimension and mechanical properties of connective tissue, blood vessels, tendons, and ligaments [ 2, 24 ] . Here, we coated three strands of CLFs loaded with sub-micrometer beads on the outside, and braided them manually into a triple stranded fi ber.
Winding is commonly used in textile for thread storage on mandrels, but not as the fi nal product. However, in tissue engineering, tissue constructs can be made by winding. Here, we fabricated tubular structures by winding a thread double-coated with MC3T3 cells and HUVECs on an 18 gauge syringe needle (diameter: 1.2 mm) serving as a mandrel. Figure 4 d shows that the gel layer remained intact even after the winding process indicating that CLF could withstand bending with a short radius of curvature. The winded structure can be separated from the needle forming a 3D tubular construct, which could be used to form artifi cial blood vessels. [ 6 ] In embroidery, threads are woven into an existing fabric, which is widely used to add decorative imagery to textiles such as caps and t-shirts. To illustrate the possibility of using CLFs for embroidering, the fi bers were secured in a needle and manually sewn through an electrospun poly(glycerol sebacate) (PGS) and poly(ε-caprolactone) (PCL) scaffold (Figure 4 e) . A linear pattern was formed by stitching a composite thread containing human breast cancer (MDA-MB-231/GFP) (Figure 4 e,ii), while preserving the integrity of the fi bers and the scaffold (Figure 4 e,iii). These results indicated that it may be possible to embroider larger structures with different types of threads on preformed biocompatible scaffolds.
Textile techniques facilitate the co-culture of various cells in predefi ned patterns. However, one major concern is the cellular viability and function after the assembly process. To investigate the cellular activity after CLFs assembly, we created CLFs containing HUVECs, NIH 3T3 fi broblasts, and HepG2 hepatocytes and braided them to form a co-culture of these cells as a representative model of liver ( Figure 5 a) . We incorporated GelMA into Ca-alginate layer to provide cells with binding sites to help with maintaining their viability and activity over the culture time. GelMA is derived from denatured collagen, which is an abundant protein found in the human body. Adding GelMA to the Ca-alginate matrix improved the adhesion of cells and enhanced their functional activities (see Figure S2b -d, Supporting Information). The fabricated braided structures were kept in culture for 16 days and cellular activity was confi rmed by observing a signifi cant increase in the measured secreted albumin (Figure 5 b) .
A key advantage of CLFs is the possibility of tuning the mechanical properties of the fi bers and the constructs. We formed wetspun alginate fi bers (4% w/v, 1 mm in diameter) and composite reinforced fi bers with a core of braided suture thread (200 µm in diameter), a shell of Ca-alginate (2% v/w, 200 µm thick) and assembled them into braided structures. We measured the tensile properties of the alginate and CLFs individually. The Young's modulus of alginate fi ber was 3.72 ± 0.62 MPa in comparison with 10 495 ± 1719 MPa for CLFs. The signifi cant difference between the mechanical properties of hydrogel and CLFs is due to the load bearing characteristics of the core layer. Thus, it is expected that the mechanical properties of the tissue construct can be tuned by selecting different core materials. The mechanical properties of braided structures fabricated using alginate and CLFs with PGA core were 1.98 ± 0.75 MPa and 3162 ± 706 MPa, respectively. These values indicate that a wide range of mechanical properties that can be achieved by assembly of fi bers using braiding. The same principle is most certainly extendible to the other textile techniques discussed in this paper.
Conclusion
Textile technologies have been widely utilized in tissue engineering, but have been mostly limited to the fabrication of reinforcing structures and polymeric tissue scaffolds. Here, we introduced the fabrication of CLFs, which comprise of load bearing core fi ber and a sheath of cell-laden hydrogel. Continuous reel-to-reel fabrication of CLFs was demonstrated by drawing a core fi ber through multiple reservoirs containing cell-laden prepolymer (Na-alginate) and crosslinking reagents (CaCl 2 ). We characterized the fabrication process and showed that by adjusting the drawing speed and the prepolymer concentration, hydrogel layers with the thickness of 50-250 µm could be made. Moreover, by passing the core fi bers through multiple reservoirs, each containing a mixture of Na-alginate and a different cell, a co-culture of different cells on the same fi ber was demonstrated. The biocompatibility of the CLF fabrication process was confi rmed by a cellular viability assessment. Cell viability was high after the manufacturing process. Results using alginate:GelMA fi bers suggest that CLFs promoting cell adhesion, proliferation, and differentiation could be fabricated. The fi bers were assembled using all major textile processes including weaving, knitting, braiding, and embroidering under sterile conditions. Our results indicate that the adhesion of the gel layer to the core thread was strong enough to withstand the mechanical loads imposed during the textile assembly processes. We braided three different CLFs containing NIH 3T3 cells, HepG2 cells, and HUVECs, respectively as a model for liver. The structures were incubated for 16 days and the concentration of albumin secreted by cells was determined as a measure for cellular activity.
The concept of CLFs is versatile and maybe applicable to a wide range of biocompatible materials including photo-(e.g., GelMA) and thermally-(e.g., collagen) crosslinkable polymers. In addition, the CLFs formation and tissue assembly processes can be completed in a matter of hours, therefore hydrolytically degradable polymers such as PGA and PLLA might also be used as core materials. We believe that CLF will serve as a Living fabrics made by using threads coated with cell-containing hydrogels using the most common textile manufacturing processes. a) Woven cell-laden CLFs: i) Schematic of the weaving process. The weaving process includes passing weft threads through warp threads, which are separated by raising or lowering heddles. ii) The woven structure includes monofi lament suturing thread as warp and multifi lament braided suturing threads coated with HEK293 cells as weft. The white section of the woven fabric is cell-free cotton thread. The size of the woven structure is 1.5 cm by 2 cm. iii) Fluorescent image of the woven structure showing the cells (red) on weft threads and iv) close up view of the dashed box in (iii). b) Knitted structures: i) Schematic of the knitting (crochet) process (ii); iii) HEK293 cell (red)-laden hydrogels were coated on suturing thread and manually knitted to form a chain-like structure; iv) Close up view of the dashed box in (iii). v) A composite knitted structure including threads coated with red and green beads; vi) A donut shape knitted structure coated with HEK293 cells. c) Braided textiles formed from intertwining three gel-coated threads. The fl orescent image shows a braided structure made from one uncoated and two coated (red and green) threads. 
Experimental Section
Materials : Sodium alginate, calcium chloride (CaCl 2 ), ethylenediaminetetraacetic acid (EDTA), type-A porcine skin gelatin, and methacrylic anhydride (MA) were purchased from Sigma Aldrich (St. Louis, MO, USA). A photoinitiator (PI) was purchased from Irgacure 2959. Dulbecco's modifi ed Eagle medium (DMEM), Alpha Minimum Essential Medium (MEM Alpha) fetal bovine serum (FBS), 0.05% trypsin-EDTA (1X), and antibiotics (Penicillin/Streptomycin) were purchased from Invitrogen (Burlington, ON, Canada). A fi nal DMEM solution was prepared with 10% FBS and 1% antibiotics (penicillin/ streptomycin). LIVE/DEAD Viability/Cytotoxicity Kit, for mammalian cells was purchased from Invitrogen (Burlington, ON, Canada). Other chemicals were purchased from Sigma Aldrich (St. Louis, MO, USA) unless mentioned otherwise.
Sodium alginate was dissolved in distilled water at a desired concentration. The solution was stirred overnight at 40 °C then stored at 4 °C and used for experiments for up to 2 months. Calcium chloride was dissolved in tris-buffered saline (TBS) with a 2% (w/v) concentration and its pH was adjusted to 7.0. As a chelating solution, a solution of 20 m M EDTA in 1X phosphate buffer saline (PBS) was made and stored at 4 °C. We dissolved type-A porcine skin gelatin (Sigma-Aldrich) in Dulbecco's phosphate buffered saline (DPBS) (GIBCO) and kept it at 60 °C to make a uniform gelatin solution with desired concentration. Methacrylic anhydride was slowly added to the gelatin solution under stirring conditions. Unreacted MA and additional chemicals were removed from the solution by dialyzing the solution against deionized water using 12-14 kDa cut-off dialysis tubes (Spectrum Laboratories) for 7 days at 50 °C. The solution was freeze-dried at −80 °C, under vacuum, and stored at room temperature. All solutions were sterilized and fi ltered by a 0.22 µm fi lter and degassed by placing them in a vacuum desiccators connected to a vacuum pump to remove bubbles.
Threads : Absorbable surgical suturing threads were purchased from SouthPointe Surgical (SoutPoint Surgical Supply, Inc., FL, USA). We used monofi lament (MON-OASIS; material: polydioxanone; absorbs by hydrolysis in 180-220 days; size: 2-0 and 3-0), braided (VI-OASIS; material: polyglycolic acid; absorbs by hydrolysis in 60-90 days; size: 2-0 and 3-0), plain gut (GUT-OASIS; material: natural purifi ed collagen; size: 2-0) suturing threads. Non absorbable suturing threads that were made from cotton threads (100% Cotton yarn Ne 30/1, Mahabad Riss Co, Iran) were used as received.
Fabrication of Electrospun Scaffolds : PGS-PCL sheets with different compositions were spun using a conventional electrospinning set-up. Fibers were collected on an aluminum foil coated with a layer of mineral oil. We dissolved PGS and PCL with the ratio of 3:1 in an anhydrous chloroform: ethanol (9:1) mixture and electrospun the fi bers at 20 kV. The total polymer concentration was kept constant at 33% w/v. Other parameters, such as the distance between the needle and the collector (18 cm), fl ow rate (2 mL h −1 ) and needle diameter (21G) were kept constant during fi ber fabrication. The scaffolds were spun for 20 min and dried overnight in a desiccator to remove any remaining solvent prior to further use.
Fabrication of Wetspun Living Fibers : We followed a conventional wetspinning process in which Na-alginate (4% w/v) was mixed with fl ourescent microbeads or cells and then injected in a bath of CaCl 2 using a syringe pump. Upon injection Ca-alginate is formed in a matter of seconds which is insoluble in water. The size of the fi bers can be controlled by changing the size of the injection needle as well as the viscosity of the solution. Here, we used 25G needles and an injection fl ow rate of 2 mL min −1 , which resulted in the formation of fi bers with 0.8 mm diameter.
Cell Culture : Human embryonic kidney (HEK293), human breast cancer (MDA-MB-231/GFP), green fl ourescent protein (GFP)-expressing human umbilical vein endothelial cells (HUVECs), mouse fi broblast cells (NIH-3T3), human hepatocytes (HepG2), and osteoblast precursor cell line derived from Musmusculus (mouse) calvaria (MC3T3) were purchased from American Type Culture Collection (ATCC) (Manassas, VA, USA). All cell lines were grown in 5% CO 2 at 37 °C in tissue culture polystyrene fl asks. HEK293, MDA-MB-231/GFP, NIH-3T3, and HepG2 cells were cultured in DMEM containing 10% fetal bovine serum (FBS) and 1% antibiotics (penicillin/streptomycin). HUVEC cells were cultured in endothelial cells basal medium (EBM-2; Lonza) supplemented with endothelial growth BulletKit (EGM-2; Lonza), 2% fetal bovine serum, vascular endothelial growth factor (VEGF). MC3T3 cells were cultured in MEM Alpha with ribonucleosides, deoxyribonucleosides, 2 m M L-glutamine and 1 m M sodium pyruvate. All cells were passaged every 3 days and cells passages 10-20 were used during all experiments. Cell medium was replaced every 3 days with fresh cell medium for long incubation times.
Preparation of Cell Suspension in Sodium Alginate : Cells that reached 80-90% confl uency were trypsinized, resuspended in corresponding cell media, and mixed with 4% sodium alginate with a ratio of 1 to 7 to reach fi nal cell concentrations in the range of 2-5 × 10 6 cells mL −1 . For better visualization of structures formed by reinforced cell-laden fi bers, HEK293 cells were stained with CellTracker (Invitrogen, Burlington, ON, Canada) according to the manufacturer's protocol before their suspension in sodium alginate.
Preparation of Cell Suspension in Sodium Alginate:GelMA Mixture : To produce alginate:GelMA fi bers, we dissolved the freeze-dried GelMA and Na-alginate power, and PI in DPBS at desired fi nal concentrations. We used 0.5% (w/v) of photoinitiator for all experiments. To create CLFs hydrogels, we used alginate:GelMA (2%:10% w/v) mixture in our coating device and to coat a layer of hydrogel on the surface of the threads. We then expose the CLFs to UV for 30 s to crosslink GelMA and form an hydrogel.
Microscopy Analysis : Microscopy images were taken using a Zeiss Axiovert 40CFL (Carl Zeiss Canada Ltd., Toronto, ON, Canada) and an inverted Nikon TE2000 microscope (TE2000, Nikon, Saint-Laurent, QC, Canada). Images were recorded using a cooled CCD camera (Photometrics CoolSNAP HQ2) connected to the microscope. Black and white images were colored and merged using the software ImageJ 1.45 s (National Institutes of Health Maryland).
Tensile Test : CLFs and hydrogel fi bers were fabricated and cut into pieces of 100 mm long. The samples were kept in PBS and their tensile properties were measured using an Instron 5542 mechanical tester. The fi bers were sandwiched between the grips and were stretched at a constant strain rate of (0.1 mm min −1 ). The fi bers were kept hydrated using an ultrasonic humidifi er during the test, four samples for each type was tested. Similarly, CLFs and wetspun alginate fi bers were manually braided into approximately 100 mm long pieces. The braid fi bers were tested using the same procedure.
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